跳至主要内容
临床试验/NL-OMON33970
NL-OMON33970已完成不适用

Assessment of tumor hypoxia in laryngeal cancer with 18F-fluoroazomycin arabinoside (18F-FAZA)-PET/CT scanning, oxygen-enhanced MRI (OE-MRI) and immunohistochemistry - 18F-FAZA-PET and OE-MRI in laryngeal cancer

niversitair Medisch Centrum Groningen0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational non invasive

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Patients with primary or recurrent squamous cell carcinoma of the larynx in whom total laryngectomy is considered the treatment of choice.
  • * Glottic, subglottic or supraglottic larynxcarncer
  • * Tumor volume more than 2 cm3
  • * WHO performance: 0-2
  • * Patients older than 18 years
  • * Written informed consent

排除标准

  • * Patient who does not sign the consent
  • * Pregnancy
  • * Patients younger than 18 years
  • * Contraindications MRI, as
  • o Pacemakers / ICD's (cochlear implant, baclofenpump, insulin-pump
  • o Severe renal insufficiency (eGFR <= 30)
  • o Claustrophobia
  • o Patients with known gadolinium allergy

研究者

相似试验

Assessment of tumor hypoxia in laryngeal cancer with... | 临床试验